LSTA - Latest News
Lisata Therapeutics, Inc. (LSTA), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $9.2M. Beta to the broader market is 0.80.
The article list below shows the most recent LSTA headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent LSTA Headlines
Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
globenewswire.com - Oct 14, 2026
Veteran biopharma CFO brings more than 15 years of public-company financial leadership across development, approval and commercial launch; joins Audit
Head to Head Analysis: GeoVax Labs (NASDAQ:GOVX) vs. Lisata Therapeutics (NASDAQ:LSTA)
defenseworld.net - Oct 11, 2026
Lisata Therapeutics (NASDAQ: LSTA - Get Free Report) and GeoVax Labs (NASDAQ: GOVX - Get Free Report) are both small-cap healthcare companies, but whi
Lisata Therapeutics wins new US patent for pancreatic cancer drug
proactiveinvestors.com - Oct 8, 2026
Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE) has been granted a new US patent covering its experimental drug certepetide for the treatment of pancre
Lisata Therapeutics Announces New Method of Use Patent Granted for Certepetide in the Treatment of Pancreatic Cancer and Other Solid Tumors
globenewswire.com - Oct 8, 2026
LIBERTY CORNER, N. J.
Lisata subsidiary Marea treats first patient in MAR002 acromegaly trial
proactiveinvestors.com - Oct 5, 2026
Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE) subsidiary Marea Therapeutics has dosed the first patient in a Phase 2 clinical trial of MAR002, a firs
How News Affects LSTA Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track LSTA's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked LSTA news questions
- What is the latest LSTA news headline?
- The most recent LSTA headline (Oct 14, 2026) is "Lisata Therapeutics Appoints Jeff Farrow to Board of Directors". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the LSTA news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What LSTA news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual LSTA options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.